Ebook: Precision haematological cancer medicine

Precision medicine and future therapeutics -- Classifications and risk factors -- Historical milestones -- Acute myeloid leukaemia -- Acute lymphoblastic leukaemia -- Chronic myeloid leukaemia -- Myeloproliferative neoplasms -- Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms -- Leukaemias of mature B and T/NK cells -- Hodgkin lymphoma -- Non-Hodgkin lymphoma -- Plasma cell neoplasms -- Principal treatment-related side-effects -- Concluding thoughts.;Many experts now consider genetic evaluation to be pivotal for the optimal diagnosis, classification, risk stratification, and therapeutic decision-making for persons diagnosed with blood cancer. This new text specifically focuses on the genetic alterations essential for establishing diagnosis and assesses how they might impact the precision oncology standard of care. Providing an authoritative review of the state of the art, this is essential reading for physicians, hematologists, and oncologists for optimal management of individual patients.